These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis. Szilasiová J; Gdovinová Z; Jautová J; Baloghová J; Ficová M; Bohus P Clin Neuropharmacol; 2009; 32(5):301-3. PubMed ID: 19820436 [TBL] [Abstract][Full Text] [Related]
9. Menstrual delay and dysfunctional uterine bleeding associated with antiprostaglandin therapy for dysmenorrhea. Halbert DR J Reprod Med; 1983 Sep; 28(9):592-4. PubMed ID: 6631846 [TBL] [Abstract][Full Text] [Related]
10. Arthritis during interferon beta-1b treatment in multiple sclerosis. Altintas A; Alici Y; Melikoğlu M; Siva A Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998 [TBL] [Abstract][Full Text] [Related]
11. Pediatric Vaginal Leech Infestation with Severe Bleeding: A Case Report and Review Article. Majidi S; Hiradfar M; Shojaian R; Mohammadipour A; Khazravi MM; Fata A J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):420-424. PubMed ID: 30928531 [TBL] [Abstract][Full Text] [Related]
12. Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a. Kumar N; Rodriguez M Mult Scler; 2004 Feb; 10(1):85-6. PubMed ID: 14760958 [TBL] [Abstract][Full Text] [Related]
13. Vaginal bleeding in adolescents. Gidwani GP J Reprod Med; 1984 Jun; 29(6):417-20. PubMed ID: 6747972 [TBL] [Abstract][Full Text] [Related]
14. [Current status of interferon beta-1b in multiple sclerosis therapy]. Hartung HP Med Klin (Munich); 2001 Sep; 96 Suppl 1():11-6. PubMed ID: 11603110 [TBL] [Abstract][Full Text] [Related]
15. [On treatment of uterine bleeding caused by hormonal disorders]. Skiftis T Z Arztl Fortbild (Jena); 1965 Feb; 59(3):124-8. PubMed ID: 4287315 [No Abstract] [Full Text] [Related]
16. The Use of "Natural" Substances for Menstrual Hygiene: A Case Report of an Embedded Vaginal Sea Sponge. Golub SA; Pham DQ; Oelschlager AA J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):83-85. PubMed ID: 36162721 [TBL] [Abstract][Full Text] [Related]
17. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423 [TBL] [Abstract][Full Text] [Related]
18. [Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b]. Río J; Marzo ME; Tintoré M; Borrás C; Montalbán X Neurologia; 1998 Nov; 13(9):422-6. PubMed ID: 9883016 [TBL] [Abstract][Full Text] [Related]
19. Concurrent administration of interferon alfa-2b and beta-1a. Tanvetyanon T; Stadtmauer EA; Kerson LA Ann Pharmacother; 2003 Jan; 37(1):77-9. PubMed ID: 12503938 [TBL] [Abstract][Full Text] [Related]
20. Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferone. Nabavi SM; Koupai SA; Nejati MR; Garshasbi E; Jalali MR Acta Med Iran; 2010; 48(1):36-41. PubMed ID: 21137667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]